Tweet
<img alt="" height="1" width="1" />
Oncothyreon drug trial stops, shares tumble
Bizjournals.com
Oncothyreon Inc. said that a clinical trial for its Stimuvax drug being conducted by Merck Serono has been halted after a “suspected unexpected serious adverse reaction” by a patient in the trial. Shares in the Seattle biotech (NASDAQ: ONTY) dropped ...
Oncothyreon partner suspends cancer drug studiesThe Associated Press
Oncothyreon partner suspends cancer drug studiesBusinessWeek
Oncothyreon plunges; Perrigo climbsMarketWatch
RTT News -Xconomy -Reuters
all 116 news articles »
More...